Markets:

Overview

News

Currencies

International

Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

3.740 -0.060 (-1.58%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about MacroGenics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

MacroGenics (NASDAQ:MGNX): A Minervini Trend Template High-Growth Momentum Case Study ↗

September 18, 2026

Via Chartmill

Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited. ↗

August 18, 2026

The company's HIV franchise is stronger than ever, and it's adding a stable of oncology drugs.

Via The Motley Fool

MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates ↗

May 27, 2026

MacroGenics (NASDAQ:MGNX) Chief Executive Officer Eric Risser said the biotechnology company has strengthened its balance sheet through two recent transactions while preparing for a series of clinical...

Via MarketBeat

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

May 12, 2026

Via Chartmill

A Look at Macrogenics's Upcoming Earnings Report ↗

May 12, 2025

Via Benzinga

Peeling Back The Layers: Exploring Macrogenics Through Analyst Insights ↗

November 07, 2024

Via Benzinga

Macrogenics Earnings Preview ↗

November 04, 2024

Via Benzinga

Macrogenics Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗

September 18, 2024

Via Benzinga

MGNX Closes Up 45% On Wall Street Optimism For Experimental Cancer Therapies ↗

March 10, 2026

Barclays increased the price target on the stock to $4 from $3 and kept an ‘Overweight’ rating on the shares.

Via Stocktwits

Which stocks are moving on Tuesday? ↗

March 10, 2026

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

March 10, 2026

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 13, 2025

Via Benzinga

Evaluating Macrogenics: Insights From 8 Financial Analysts ↗

August 15, 2024

Via Benzinga

What's going on in today's after hours session ↗

September 16, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 21, 2025

Via Benzinga

Thursday's after hours session: top gainers and losers ↗

August 21, 2025

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

MacroGenics Revenue Doubles in Q2 ↗

August 14, 2025

Via The Motley Fool

Which stocks have an unusual volume on Wednesday? ↗

June 11, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Which stocks are gapping on Tuesday? ↗

June 10, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 10, 2025

Via Benzinga

4 Analysts Assess Macrogenics: What You Need To Know ↗

May 20, 2025

Via Benzinga

Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

March 24, 2025

Via Benzinga

MacroGenics (MGNX) Q4 2024 Earnings Call Transcript ↗

March 20, 2025

MGNX earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Earnings Scheduled For March 20, 2025 ↗

March 20, 2025

Via Benzinga

MacroGenics (MGNX) Q3 2024 Earnings Call Transcript ↗

November 05, 2024

MGNX earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

After Reporting Five Patient Deaths, Data Committee Recommends MacroGenics Halt Prostate Cancer Trial ↗

July 31, 2024

MacroGenics will discontinue vobra duo for remaining mCRPC participants after five deaths. New data to be presented at ESMO 2024 conference.

Via Benzinga

Topics Death

Match Group Layoffs 2024: What to Know About the Latest MTCH Job Cuts ↗

July 31, 2024

Match Group layoffs are a hot topic on Wednesday as the dating website operator is preparing to reduce its headcount due to demand changes.

Via InvestorPlace

Topics Workforce

Why is Macrogenics (MGNX) Stock Down 28% Today? ↗

July 31, 2024

Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.